RxDoctor Payments Data

Hugo Rodela, APRN

Nurse Practitioner · Dodge City, KSNPI 1396151775

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $4,299 of the $6,925 with a category attached, or 62.1%. Medtronic accounts for 89.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $2,375 and has fallen 50.8% since, to $1,168 in 2025. Among nurse practitioner clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,925in general payments, 2019–2025

Across 67 payments — averaging $103.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$6K
  • Welch Allyn$570
  • Merck$114
  • Shockwave Medical, Inc$28
  • Johnson & Johnson$16
  • Philips North America LLC$14

What the payments were for

  • Travel & lodging$4,29962%
  • Food & beverage$2,01029%
  • Education$451%
  • Other$5708%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,925 in reported general payments places this provider in the 95th percentile of 1,326 nurse practitioner providers in Kansas.

See all nurse practitioner providers in Kansas

Medicare billing

Part B allowed, 2024
$31,814
Medicare patients
196
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$53,202
XareltoRivaroxaban44$39,400
Repatha SureclickEvolocumab15$15,531
JardianceEmpagliflozin15$15,528
EntrestoSacubitril/Valsartan13$14,251
FarxigaDapagliflozin Propanediol11$6,424
Metoprolol Succinate242$2,629
Losartan Potassium160$1,424
Atorvastatin Calcium144$1,212
Amlodipine Besylate171$1,001
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide20$908
Metoprolol Tartrate127$636
Carvedilol88$530
Ezetimibe27$491
Potassium Chloride31$458

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$16$39,40044 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,326 nurse practitioner providers in Kansas.

Other nurse practitioner in Dodge City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →